Condition: Fontan Circulation · Single Ventricle Heart Disease · HFpEF - Heart Failure With Preserved Ejection Fraction · Sponsor: Mayo Clinic
The purpose of this research is to determine whether treatment with the study drug dapagliflozin for 3 months affects peripheral venous pressure at rest and during exercise in adults with failing Fontan circulation.
This description comes directly from the study's public registry record.
Amanda Wozniak · 507-266-1976 · Wozniak.Amanda@mayo.edu
Yusef Maarouf · 507-422-5755 · Maarouf.Yusef@mayo.edu
Always discuss trial participation with your own doctor first.
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06762964